Skip to main content
. 2016 Feb 3;1:15015. doi: 10.1038/npjgenmed.2015.15

Figure 2.

Figure 2

Individual impact of CCL5, DDIT4 and POLR1C genes recurrence-free survival (RFS) in triple-negative breast cancer patients (using the median of expression as cutoff) in the database of the online platform kmplot.org. (a) High expression of CCL5 was associated with good prognosis (P=0.0012). (b) High expression of DDIT4 confers poor prognosis (P=0.00034). (c) Expression of POLR1C was not significantly associated with the RFS in all patients (P=0.28); however, (d) excluding systematically untreated patients, a significant association is observed (0.0059).